Clinical Trial Update: Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the safety and effectiveness of EPA versus DHA omega-3 fatty acids for the treatment of major depressive disorder has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)
• Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-07-18